Psyomics
Cambridge
About Psyomics
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.5M
- Last round: Non-Equity Assistance (Apr 2025)
- Website: psyomics.com
- Phone: +44 (0) 1233 437131
Industries & Categories
Biotechnology, Health Care, Medical, Universities
Social Profiles
Canonical: https://fsome.com/organization/psyomics-63574 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.